(Other OTC:AONC),(OTC US:AONC), FORT MYERS, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) — Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its clinic in Fort Myers to 14551 Hope Center Loop. The newly expanded clinic includes 12 exam rooms, nearly 30 infusion chairs, and an onsite lab. Current or prospective […]

(PinkSheets:EBYH),(Pinksheets:EBYH), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Strainsforpains, Inc. fka/ E-Buy Home, Inc. (OTC: EBYH). Strainsforpains, Inc. is redefining the future of wellness, cannabis innovation, and AI integration. With a transformative year in the books, the company is poised to disrupt multiple industries and deliver groundbreaking results in 2025. Unparalleled Revenue Growth and

REDWOOD CITY, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — The enterprise AI infrastructure and graph database leader TigerGraph today announced Savanna, the next generation cloud offering, extending its market leadership as the graph database designed for companies that need to quickly discover relationships, analyze complex patterns, and make mission critical decisions across large amounts of

(PinkSheets:VDRM),(Pinksheets:VDRM), LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) — ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, is pleased to announce the opening of a satellite office in Dubai to facilitate its ongoing expansion in the Middle East. Local regulations require businesses to maintain a physical office within

(NasdaqGM:CRMD), BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces it has engaged with WSI PBG, a subsidiary of Golden State Medical Supply, to promote DefenCath(R) to healthcare providers in facilities operated by the

(NASDAQ:REPL), WOBURN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for RP1 (vusolimogene oderparepvec) in combination with nivolumab for patients with advanced

SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) — QuestionPro, a global leader in online survey and research services, has acquired the Happy Market Research Podcast (HMRP). With more than 480 episodes and 268,000 listens, the HMRP has become one of the most popular and influential market research industry podcasts. The podcast will now be called

(NASDAQ:PCRX), — Brendan Teehan named Chief Commercial Officer and Krys Corbett named Chief Business Officer — — Key additions expected to support company's 5×30 path to becoming an innovative biopharmaceutical organization — PARSIPPANY, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid

(Madrid:ORY.MC),(Boerse Stuttgart – Freiverkehr: ORN), MADRID, Spain and CAMBRIDGE, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, is pleased to announce the appointment of Dr. Pierre Beaurang as Strategy and Business Development Advisor.

(NYSE MKT:CVU), EDGEWOOD, N.Y., Jan. 21, 2025 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero(R)” or the “Company”) (NYSE American: CVU) announced that it has received several contracts totaling $4.3 Million for gunner window assemblies for the UH-60M Black Hawk(R) helicopter as part of a previously announced five-year, indefinite delivery indefinite quantity (IDIQ) contract. “CPI